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INTRODUCTION
Insulin resistance and insulin-secretion
derangement are correlated in a stable
manner and both play a pivotal role in
the onset of Type 2 Diabetes Mellitus
(T2DM). In fact, e.g., insulin-secretion is
physiologically ruled by insulinemia, by
means of a feed-back mechanism, through
insulin-receptors localized on the mem-
brane of insular β-cell: the two factors are
strictly related each other at large num-
ber of different levels. Due to these reasons
the clinical on-set of T2DM appears later,
because insulin-resistance in liver (Zenda
et al., 2003), adipose cells of the abdomen
wall and skeletal muscles during the ini-
tial stage, i.e., for years or decades, may
be balanced by increasing of the insulin
secretion. It is generally admitted that
the T2DM may occur at a flurry num-
ber of years before the clinical diagnosis
is made. Importantly, during the time that
diabetes is undiagnosed and untreated,
“complications,” that could be avoided, are
developing. With the aim of an early pre-
metabolic diagnosis we introduce a clinical
method to assess the Inherited Real Risk
(IRR) of T2DM by means of Quantum
Biophysical Semeiotics (QBS), which is an
extension ofmedical semeiotics (Stagnaro-
Neri and Stagnaro, 2004), interpreting an
awful number of QBS signs for diagnos-
tic purposes. The key of this new discipline
is the awareness that human bodies are
a continuum of biological systems whose
dynamics follow the laws of deterministic
chaos, which can be measured by means of
nonlinear statistical invariants.
QBSMETHOD: IRR OF T2DM
DIAGNOSIS
QBS method allows the clinical and pre-
clinical diagnosis of the most severe dis-
eases, e.g., solid and liquid forms of cancer
and coronary heart diseases, as well as the
IRR of T2DM; i.e., through the ausculta-
tory percussion of the stomach (Stagnaro
and Stagnaro-Neri, 1986). Doctors can
now evaluate, with a stethoscope and the
auscultation of any viscera (i.e., stomach,
ureter), mitochondria functions as well as
the behavior of any biological system.
As regards the technical procedure,
doctors can recognize QBS “Diabetic
Constitution” in the easiest way by an
“intense” skin pinch at the level of the
VI thoracic dermatome. In a healthy
patient, “simultaneously” the gastric aspe-
cific reflex is absent, appearing after 24 s
sharp (Stagnaro and Stagnaro-Neri, 2004).
On the contrary, in patients predis-
posed to diabetes, the reflex appears
“simultaneously” (positive Siniscalchi’s
sign), showing an intensity inferior to
1 cm, while in the diabetic patient it is 1 cm
or more, in relation to the seriousness of
underlying disorder.
Among the different, consistent each
others, QBS signs useful for the diagno-
sis of “Diabetic Constitution” and IRR of
T2DM such as, i.e., the pancreatic gas-
tric aspecific reflex (Stagnaro andCaramel,
2013), we illustrate briefly the Osteocalcin
test. This original manoeuvre, based on
a singular activity of osteocalcin, is reli-
able in bedside detecting diabetes in 1min,
with the aid of a stethoscope (Stagnaro
and Stagnaro-Neri, 1986). In fact, osteo-
calcin, a product of osteoblasts, among
other action mechanisms, stimulates both
insulin secretion and insulin receptor
sensitivity.
As a consequence, osteocalcin, secreted
by the bone cells during mean-intense
lasting digital pressure—for instance—
applied upon lumbar vertebrae, brings
about increasing pancreatic diameters, i.e.,
technically speaking, type I, associated,
Langherans islet microcirculatory activa-
tion. By this way, doctors assess pancreas
size augmentation, which in health, lasts
10 s exactly. After that, pancreas diame-
ters return to its basal value for 3 s. The
second pancreas size increasing lasts 20 s,
and finally the third one shows the high-
est value: 30 s. On the contrary, in case
of diabetic constitution the first pancreas
increasing persists normally (10 s), but
both the second and the third dilations are
less than the physiological one (i.e., less
than 20 s and respectively 30 s). In presence
of intense IRR of T2DM, such as impair-
ment is greater. Finally, in case of T2DM
the alteration is present already in the first
evaluation, wherein duration appears less
than 10 s, inversely related with disorder
seriousness.
As a matter of fact, pre-hypertension
during young adulthood may be involved
by coronary calcium later in life exclu-
sively in presence of IRR of CAD, typical
for individuals with lithiasic constitu-
tion, present in about 50% of all cases
of pre-metabolic and metabolic syn-
drome (Caramel and Stagnaro, 2012).
Considering the frequent association
between hypertension and diabetes, it
is important, to recognize, bed-side,
the diabetic predisposition, now-a-days
possible from birth, utilizing a lot of
clinical methods, some of them above
mentioned.
PATHOPHYSIOLOGYOF T2DM: THE
FIRST FIVE STAGES
According to clinical and experimen-
tal evidences provided by QBS signs
and clinical diagnosis (Stagnaro and
Stagnaro-Neri, 1986, 2004; Stagnaro-
Neri and Stagnaro, 2004; Caramel and
Stagnaro, 2012; Stagnaro and Caramel,
2013) the pathophysiology of T2DM can
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be resumed in five temporal stages, which
play a key role in early diagnosis to avoid
complications and glucose metabolism
impairment:
(1) diabetic and dyslipidemic constitu-
tion, IRR of T2DM—overt, latent or
potential (individual’s birth);
(2) abnormal synthesis of perivas-
cular GAGs by fibroblasts, peri-
cytes, mioblasts, megacariocytes,
a.s.o.; Amiline in the Interstitial
Fundamental Substance, glyco-
calix malfunction in both beta-cells
and peripheral target-organ cells.
Location: Capillaries, Small Arteries,
Arterioles, AVA type II, group B,
cutaneous, Endoarteriolar Blocking
Devices (EBDs)., a.s.o. (under 10
years old);
(3) IRR of T2DM, Microalbuminurie,
Initial ATS Plaques, a.s.o. (second
decade of life);
(4) pre-diabetes, overt microvascular
complications—OGTT, Iper-Insuli-
nemic-Normo-Glicemic Clamping,
Insulinemia (about third decade of
life);
(5) Overt T2DM.
Other authors (Weir and Bonner-
Weir, 2004) introduced the idea of five
stages in the pathophysiology of T2DM.
Their approach is more about glucose
metabolism and the interplay between
beta cell function and insulin resistance,
while the one (Stagnaro, 2011) here men-
tioned is focused on complications.
Since their birth (first stage) all dia-
betic individuals show QBS signs typical
of dyslipidemic “and” diabetic constitu-
tions, and all the related IRR, based on a
mitocondrial functional cytopathy termed
Congenital Acidosis Enzimo-Metabolic
Histangiopathy (CAEMH) (Stagnaro-
Neri and Stagnaro, 2004; Caramel and
Stagnaro, 2012; Stagnaro and Caramel,
2013), subsequently evolved first into
pre-metabolic syndrome (Stagnaro and
Singh, 2009) and later on into metabolic
one, under the negative influence of well-
known environmental factors. In fact,
not “all” the individuals, even though
obese and/or hypertensive, are at risk of
diabetes mellitus, with the same proba-
bilities. On the contrary, the individuals
with diabetic IRR are all those who are
positive to dyslipidemic “and” diabetic
QBS constitutions, inherited mostly from
the mother, and associated to the diabetic
IRR, conditio sine qua non of T2DM.
The second stage of evolution to overt
T2DM is characterized by the enlarge-
ment of interstitial space, for instance in
Langherans’s islets, caused by abnormal
synthesis of local GAGs, when the pro-
duction of jaluronic acid appears partic-
ularly compromised, showing an altered
affinity for water. So that the relation
free water/bound water appears abnormally
high. ATS plaques appear from the second
decade of life (third stage). The last two
stages, pre-diabetes and overt T2DM, all
well clinically known.
The objective QBS examination allows
physicians to bedside recognize and quan-
tify, in a few minutes, the presence of
the IRR of diabetes or overt T2DM, even
initial, through the evaluation of sev-
eral semeiotics signs, i.e., assessing vaso-
motility and vasomotion impairments,
and the typical pathological EBDs (Ditzel,
1968; Stagnaro and Stagnaro-Neri, 1986,
2004; Stagnaro-Neri and Stagnaro, 2004;
Caramel and Stagnaro, 2012; Stagnaro
and Caramel, 2013). The IRR of T2DM
is characterized by a microcirculatory
remodeling due to the functional and
structural abnormalities just mentioned.
For instance, in the normal Langheran’s
islets microcirculatory bed, there are
exclusively “normal” type II (present in
arterioles, according to Hammersen), but
not type I (present in small arterioles)
EBDs, i.e., first and second class EBDs
(Curri, 1968; Ditzel, 1968). In health, i.e.,
not involved by Diabetic Constitution, we
do not observe type I, subtype b) aspe-
cific, newborn- pathological EBDs in the
above-mentioned biological system.
On the contrary, in individuals involved
by diabetic constitution as well as diabetic
IRR and overt T2DM, in its diverse stages,
we observe also newborn-pathological,
type I, subtype b) aspecific, EBDs, facil-
itating the diagnosis and consequently
diabetes primary prevention. In addition,
the evaluation of Insulin Secretion Acute
Pick (ISAP) Renal Test (Stagnaro-Neri and
Stagnaro, 1997) is significantly impaired,
corroborating the clinical diagnosis.
T2DM PRIMARY PREVENTION
The QBS method was used to mon-
itor tissue acidosis before and during
preventive therapies (Stagnaro, 2002) such
as “Modified Mediterranean Diet” (a
greater amount of fish, i.e., protein and
Omega-3 fatty acids, than the normal
Mediterranean Diet), CoQ10, melatonin
conjugated with adenosine and carnitine
(Stagnaro-Neri and Stagnaro, 1996) in
T2DM primary prevention and therapy.
The QBS therapeutic monitoring corrob-
orates the efficiency of the combination
of these treatments for preventive pur-
poses as stated by the reduced level of
tissue acidosis, the improvement of tis-
sue oxygenation (Ditzel and Standl, 1975)
and mitochondrial activity. Recent clinical
experiments done by means of a quantum
therapy able to capture and re-transmit
customized Extremely High Frequencies
(EHF) millimeter waves from pancreatic
trigger points evidence an improvement of
mitochondrial and endothelial function,
showing genetic feedbacks able to heal the
“Diabetic Constitution.”
CURRENT AND FUTURE
DEVELOPMENTS
Clinical and experimental data collected
by QBS diagnosis evidence a patho-
physiology of T2DM resumed with first
five stages. The presence of the IRR of
T2DM, evolution of a congenital “Diabetic
Constitution,” is clinically diagnosed from
birth, so that an intelligent prevention
strategy can be implemented only on those
at real risk, especially under a very early
diagnosis, done on a large scale in the first
decade of life.
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